ARTICLE | Clinical News
Visudyne verteporfin injection regulatory update
February 12, 2001 8:00 AM UTC
QLT and partner Novartis Ophthalmics (Bulach, Switzerland) said the FDA issued an approvable letter for Visudyne to treat predominantly classic subfoveal choroidal neovascularization (CNV) caused by p...